ATLANTA, Sept. 11, 2019 /PRNewswire/ -- Who are the advocates behind the response to the Flint water crisis? How has West Africa recovered from the Ebola crisis and prepared itself for future health threats? How is the Centers for Disease Control and Prevention (CDC) working with partners to elim

DENVER, Sept. 11, 2019 /PRNewswire/ -- Welltok, a data-driven, enterprise SaaS company that delivers the industry's leading consumer health activation platform, has been named to the

AUSTIN, Texas, Sept. 11, 2019 /PRNewswire/ -- Digital Pharmacist (

ST. LOUIS, Sept. 11, 2019 /PRNewswire/ -- EyeCare Partners LLC ("ECP"), a growing network of full scope medical optometry and ophthalmology practices, today announced it has completed the acquisition of Nationwide Vision ("Nationwide" or the "Company"), a leading full-service vision care provider. The acquisition continues to strengthen ECP's network of free-standin

TAMPA, Fla., Sept. 11, 2019 /PRNewswire/ -- As September shines a spotlight on childhood cancer awareness, the National Pediatric Cancer Foundation (NPCF) is bringing

LONDON, Sept. 11, 2019 /PRNewswire/ -- The 4th Annual Nursing World Conference concluded August 21st at the Park Inn by Radisson Hotel & Conference Centre, providing qualitative, quantitative, and mixed-method research presented by Chief Nurses from around the globe.Thousands of participants gathered to further their knowledge and

NEW YORK, Sept. 11, 2019 /PRNewswire/ -- The American Kennel Club® (AKC®) invites you to celebrate the human-canine bond this September 28th in Raleigh, NC at the 17th annual flagship AKC Responsible Dog Ownership Day, sponsored by

SCOTTSDALE, Ariz., Sept. 11, 2019 /PRNewswire/ -- Amendola Communications, a nationally recognized, award-winning healthcare and health IT public relations and marketing agency, has promoted Marcia Rhodes to the position of Vice President, the agency announced today. The promotion is the latest in a steady progression of responsibility

STOCKHOLM, Sept. 11, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results from the Phase 3 OPTIMUM study for ponesimod, an investigational selective S1P1 receptor modulator, showing superior efficacy on the primary endpoint and most secondary endpoints compared to Aubagio® (teri

BOSTON, Sept. 11, 2019 /PRNewswire/ -- National telehealth leader American Well® announced today that it has been named to the Forbes 2019 Cloud 100, the definitive ranking